Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain.

Source:http://linkedlifedata.com/resource/pubmed/id/17182843

Download in:

View as

General Info

PMID
17182843